Percutaneous Transluminal Angioplasty Registry

NCT02728479 · tracked via the Priya Life Science Germany tracker

Sponsor

Klinik für Kardiologie, Pneumologie und Angiologie

Phase

Observational

Started

2014-01

Last updated

2020-02-07

Condition(s) studied

Percutaneous Transluminal Angioplasty

Study summary

Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease.

The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients undergoing PTA Exclusion Criteria: * \< 18 years

Primary outcome measure(s)

Patency rate — 6 months
Creatinine level — 2 Days after PTA

Trial sites (1)

Facility	City	Region	Status
Division of Cardiology, Pulmonary Disease and Vascular Medicine	Düsseldorf	Germany	Recruiting

More Klinik für Kardiologie, Pneumologie und Angiologie trials in Germany

Registry of Device Implantation Recruiting

MitraClip® Registry Recruiting

Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02728479 on ClinicalTrials.gov ↗ ← All trials in Germany